Paola Chiodelli

Years Active: 2021-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Barbara Chiavarina, Roberto Ronca, Yukihiro Otaka, Roger Bryan Sutton, Sara Rezzola, Takehiko Yokobori, Paola Chiodelli, Regis Souche, Didier Pourquier, Antonio Maraver, Gavino Faa, Lakhdar Khellaf, Evgenia Turtoi, Tetsunari Oyama, Stephanie Gofflot, Akeila Bellahcène, Olivier Detry, Philippe Delvenne, Vincent Castronovo, Masahiko Nishiyama, Andrei Turtoi
Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma. Oncogene 41 (10) (2022)
Marco Rusnati, Giulia Paiardi, Chiara Tobia, Chiara Urbinati, Alessio Lodola, Pasqualina D'Ursi, Miriam Corrado, Riccardo Castelli, Rebecca C Wade, Massimiliano Tognolini, Paola Chiodelli
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin. Cancer gene therapy (2021)
Marco Rusnati, Giulia Paiardi, Chiara Tobia, Chiara Urbinati, Alessio Lodola, Pasqualina D'Ursi, Miriam Corrado, Riccardo Castelli, Rebecca C Wade, Massimiliano Tognolini, Paola Chiodelli
Correction: Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin. Cancer gene therapy (2021)

Paola Chiodelli.css-eqlu8i{font-size:small;padding-left:4px;}